top of page
The Five-Dimension Partner Qualification Framework That Prevents the Most Costly Mistake in MENA Pharma BD
Partner selection is the decision that most determines the quality of every subsequent phase of a MENA pharmaceutical market entry, and the decision most frequently made with the least rigorous process.
4 min read
The Four Risk Categories in International Pharma Expansion: And the Framework That Addresses All of Them
International pharmaceutical market expansion carries four categories of risk that interact and compound when any one is underestimated.
4 min read
Why Most International Pharma Partnerships Fail: And the Due Diligence Framework That Prevents It
The single most underinvested step in international pharmaceutical market expansion is partner qualification. Companies allocate months and significant budget to regulatory strategy development, commercial projections, and market analysis, then select a distributor, co-development partner, or licensing counterparty through a network introduction and a favorable first meeting.
4 min read
bottom of page